Skandinaviska Enskilda Banken Ab (Publ) Abb Vie Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.5 Billion
- Q3 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Abb Vie Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 1,348,304 shares of ABBV stock, worth $248 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
1,348,304
Previous 1,521,945
11.41%
Holding current value
$248 Million
Previous $261 Million
2.0%
% of portfolio
1.24%
Previous 1.26%
Shares
30 transactions
Others Institutions Holding ABBV
# of Institutions
3,891Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$31.6 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.5 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.62 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.12 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $325B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...